Journal Information
Vol. 54. Issue 4.
Pages 326-330 (1 April 2001)
Share
Share
Download PDF
More article options
Vol. 54. Issue 4.
Pages 326-330 (1 April 2001)
Full text access
Eficacia de un test clínico como preselección de niños con sospecha de síndrome X frágil
Effectiveness of a clinical checklist in the preselection of children with suspicion of fragile X syndrome
Visits
6972
I. Fernández Carvajala, A. Blanco Quirósa,
Corresponding author
ablanco@ped.uva.es

Correspondencia: Área de Pediatría. Facultad de Medicina. Ramón y Cajal, 5. 47005 Valladolid
, J. Fernández Toralb, J.J. Tellería Orriolsa, M.J. Alonso Ramosa, A. Sanz Cantalapiedraa, J.F. Martín Rodríguezc, R. Palencia Luancesd
a Instituto de Biología Molecular y Genética (IBGM)
b Unidad de Genética. Hospital Central de Oviedo
c Área de Estadística. Universidad de Valladolid
d Servicio de Pediatría. Hospital Clínico de Valladolid
This item has received
Article information
Antecedentes

El síndrome X frágil (SXF) es la causa hereditaria más frecuente de retraso mental. Puede diagnosticarse con técnicas de genética molecular, pero su variada expresión dificulta la sospecha clínica

Objetivo

Se valora la utilidad de un test de seis criterios clínicos como método de preselección a los niños candidatos para estudio genético del síndrome

Pacientes y métodos

Se estudiaron 70 pacientes varones entre 2 y 10 años, con retraso mental de causa desconocida, aplicándoseles un test con seis criterios clínicos (retraso mental, historia familiar de retraso mental, facies alargada, orejas grandes, conducta autística y déficit de atención) que se valoraron de 0 a 2 puntos. En todos se realizó estudio molecular del gen SXF usando reacción en cadena de la polimerasa y Southern-blot

Resultados

El estudio molecular confirmó la mutación complete (> 200 repeticiones CGG) en 14/70 (20 %) niños. La suma de 6 puntos en el test fue el límite más discriminativo y fue alcanzado por los 14 enfermos con mutación (100 %), pero sólo por 2 de 56 casos (3,5 %) sin mutación. El mejor modelo diagnóstico fue la asociación del retraso mental, deficiencia de atención e hiperactividad, historia familiar de retraso mental y orejas grandes seguido de la facies alargada y la conducta autista

Conclusión

Un test clínico de 6 parámetros facilita la preselección de niños con sospecha de SXF para ser confirmados luego con técnicas de genética molecular

Palabras clave:
Síndrome X frágil
Retraso mental
Alteraciones de la conducta
Mutaciones dinámicas
Genética molecular
Cromosoma X
Background

Fragile X syndrome (FXS) is the most frequent hereditary cause of mental retardation. It can be diagnosed by molecular genetic techniques, but clinical suspicion is made less likely by it variable expression

Objective

To assess the effectiveness of a six-item checklist in the preselection of children who are candidates for FXS genetic study

Material and methods

W e studied 70 male patients aged between 2 and 10 years with mental retardation of unknown cause. In all patients a checklist with six clinical criteria (mental retardation, history of familial mental retardation, long face, large ears, autistic-like behaviour, and attention deficit disorder with hyperactivity) measured from 0-2 points was applied and molecular genetic studies using polymerase chain reaction and Southern-blot were performed

Results

In 14 of the 70 children (20 %) molecular study confirmed full mutation (> 200 CGG repeats). A score of six points in the test had the greatest discriminatory power and was reached by 14 patients (100 %) with mutation, but only by 2 of 56 patients (3.5 %) without mutation. The most accurate diagnostic model was the association of mental retardation, attention deficit disorder with hyperactivity, large ears and a history of familial mental retardation followed by long face and autistic-like behaviour

Conclusion

The six-item checklist improved the preselection of children with suspicion of FXS, which was later confirmed by molecular genetic techniques

Key words:
Fragile X syndrome
Mental retardation
Behaviour problems
Dynamic mutations
Molecular genetics
X chro m osome
Full text is only aviable in PDF
Bibliografía
[1.]
F. Rousseau, D. Heitz, V. Biancalana.
Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation.
N Engl J Med, 325 (1991), pp. 1673-1681
[2.]
H. Lubs, J.F. Arena, L. Chiurazzi, J. Tranaabjaerg, G. Neri.
XLMR genes update 1995-1996.
[3.]
F. Ramos.
Avances en el síndrome X frágil y otras enfermedades con anticipación genética.
An Esp Pediatr, 61 (1994), pp. 79-84
[4.]
F. Ramos.
Deficiencia mental de origen genético.
An Esp Pediatr, 47 (1997), pp. 121-125
[5.]
S.L. Sherman.
The high prevalence of fragile X premutation carrier females: Is this frecuency unique to the French Canadian Populationα.
Am J Hum Genet, 57 (1995), pp. 991-993
[6.]
T. W ebb, S. Bundey.
Prevalence of fragile X syndrome.
J Med Genet, 28 (1991), pp. 358
[7.]
B.B. De Vries, D.J. Halley, B.A. Oostra, M.F. Niermeijer.
J Med Genet.
x, 35 (1998), pp. 579-589
[8.]
S.L. Sherman, P.A. Jacobs, N.E. Morton, U. Froster-Iskenius, P.N. Howard Peebles, K.B. Nielsen.
Further segregation analysis of the fragile X syndrome with special reference to transmitting males.
Hum Genet, 69 (1985), pp. 289-299
[9.]
J. Opitz.
On the gates of the helland almost unusual gene.
Am J Med Genet, 23 (1986), pp. 1
[10.]
A.J. Verkerk, M. Pieretti, J.S. Sutcliffe, Y.H. Fu, O.P. Kuhl, A. Pizzuti.
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
Cell, 65 (1991), pp. 905-914
[11.]
C.T. Caskey, A. Pizzuti, Y.H. Fu, R.G. Fenwick, D. Nelson.
Triple repeat mutations in human disease.
Science, 256 (1992), pp. 784-789
[12.]
M. Pieretti, F.P. Zhang, Y.H. Fu, S.T. Warren, B.A. Oostra, C.T. Caskey.
Absence of expression of the FMR-1gene in fragile X syndrome.
Cell, 66 (1991), pp. 817-822
[13.]
J.S. Sutcliffe, D.L. Nelson, F. Zhang, M. Pieretti, C.T. Caskey, D. Saxe.
DNA methylation represses FMR-1 transcription in fragile X syndrome.
Hum Mol Genet, 1 (1992), pp. 397-400
[14.]
A. McConkie-Rosell, A.M. Lachiewicz, G.A. Spiridigliozzi, J. Tarleton, S. Schoenwald, M.C. Phelan.
Evidence that methylation of the FMR-1locus is responsible for variable phenotypic expression of the fragile X syndrome.
Am.J Med Genet, 53 (1993), pp. 800-809
[15.]
A. Smits, D. Smeets, B. Hamel, J. Dreesen, A. D-Haan, B. Van-Oost.
Prediction of mental status in carriers of the fragile X mutation using CGG repeat length.
Am J Med Genet, 51 (1994), pp. 497-500
[16.]
R.J. Hagerman, K. Amiri, A. Cronister, X. Fragile.
Fragile X checklist.
Am J Med Genet, 38 (1991), pp. 283-287
[17.]
E. Goldson, R.J. Hagerman.
The fragile X syndrome.
Devel Med Child Neurol, 34 (1994), pp. 822-832
[18.]
R.J. Hagerman.
Physical and behavioral phenotype.
Fragile X Syndrome: Diagnosis and Treatment, pp. 212-310
[19.]
L.S. Crabbe, A. Bensk, L. Hornstein, D. Schwartz.
Cardiovascular abnormalities in children with fragile X syndrome.
Pediatrics, 91 (1993), pp. 714-715
[20.]
R.J. Hagerman, D.P. Synhorst.
Mitral valve prolapse and aortic dilatation in the fragile X syndrome.
Am J Med Genet, 17 (1984), pp. 123-131
[21.]
S.L. Freund, A.L. Riess.
Cognitive profiles associated with the fra (X) syndrome in males and females.
Am J Med Genet, 38 (1991), pp. 542-547
[22.]
I. Oberle, F. Rousseau, D. Heitz, C. Kretz, D. Devys, A. Hanaver.
Inestability of a 550bpDNA segment and abnormal methylation of in fragile X syndrome.
Science, 252 (1991), pp. 1097-1102
[23.]
Y.H. Fu, D.P. Kuhl, A. Pizzuti, M. Pieretti, J.S. Sutcliffe, S. Richards.
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.
Cell, 67 (1991), pp. 1047-1058
[24.]
R.G. Pergolizzi, S.H. Erster, P. Goonewardena, W.T. Brown.
Detection of full fragile X mutation.
Lancet, 339 (1992), pp. 271-272
[25.]
F.M. Ausubel, R. Brent.
Kingston.
pp. 1-5
[26.]
C.A. Giangrec, M.W. Steele, C.E. Aston, J.H. Cummins, S.L. Wenger.
A simplified six-item checklist for screening for fragile X syndrome in the pediatric population.
J Pediatr, 129 (1996), pp. 611-614
[27.]
S. Hecimovic, I. Barisic, K. Pavelic.
DNA analysys of the fragile X syndrome in an at risk pediatric population in Croatia: simple clinical preselection criteria can considerably improve the cost-effectiveness of fragile X screening studies.
Hum Hered, 48 (1998), pp. 256-265
[28.]
M.G. Butler, T. Mangrum, R. Gupta, D.N. Singh.
A 15 item checklist for screening mentaly retarded males for the fragile ´ syndrome.
Clinical Genet, 39 (1991), pp. 347-354
[29.]
M. Arvio, M. Peippo, K.O. Simola.
Applicability of a checklist for clinical screening of the fragile X syndrome.
Clin Genet, 52 (1997), pp. 211-215
[30.]
M. Mila, S. Castellvi-Bel, A. Sanchez, C. Lazaro, M. Villa, X. Estivill.
Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR-1 gene.
J Med Genet, 33 (1996), pp. 338-340
[31.]
E. De Graaff, P. Rouillard, P.J. Willens, A.P. Smits, F. Rousseau, B.A. Oostra.
Hot spot for deletions in the CGG repeat region of FMR-1 in fragile X patiens.
Hum Mol Genet, 4 (1995), pp. 45-99
[32.]
K. De Boulle, A.J. Verkerk, E. Reyners, L. Vits, J. Hendrickx, B. Van Roy.
A point mutation in the FMR-1 gene associated with fragile X mental retardation.
Nature Genet, 3 (1993), pp. 31-35
[33.]
J.B. Vincent, D.S. Koneck, E. Munstermann, P. Bolton, A. Poustka, F. Poustka.
Point mutation analysis of the FMR-1 gene in autism..
Mol Psychiatric, 1 (1996), pp. 227-231
[34.]
Y.C. Wang, M.L. Lin, Y.C. Lin, Y.C. Li, S.Y. Li.
Novel point mutation within intron 10 of FMR1 gene causing fragile X syndrome.
[35.]
A.K. Gedeon, E. Baker, H. Robinson, M.W. Partington, B. Gross, A. Manca.
Fragile X syndrome without CGG amplification has an FMR-1 deletion.
Nature Genet, 1 (1992), pp. 341-344
[36.]
H. Meijer, E. De Graaff, D.M. Merkx, R.J. Jargbloed, C.E. de Die Smulders, J.J. Engelen.
A deletion of 1.6Kb proximal to the CGG repeat of the FMR-1 gene causes the clinical phenotype of the Fragile X syndrome.
Hum Mol Genet, 3 (1994), pp. 615-620

Trabajo realizado parcialmente con una ayuda a la investigación de la Junta de Castilla y León (ref. VA 04/95)

Copyright © 2001. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?